Corporate document

Appendix 1 – Framework development process

Appendix 1 – Framework development process

Commission and funding source

This piece of work has been commissioned and funded by NHS England and Improvement. The project sponsors are:

  • Jonathan Berry, personalisation and control specialist, NHS England and NHS Improvement

  • Paul Chrisp, director of the centre for guidelines, NICE.

The NICE project leads are:

  • Andy Hutchinson, medicines education technical adviser, NICE

  • Victoria Thomas, head of public involvement, NICE.

Oversight

Oversight of the work was undertaken by a group of experts:

  • Adrian Edwards, University of Cardiff

  • Angela Coulter, academic

  • Carole Pitkeathley, lay contributor

  • Helen Morgan, palliative care consultant, Northumbria Healthcare NHS Trust

  • Hilary Bekker, University of Leeds

  • Louisa Polak, GP, Cambridge Primary Care Unit

  • Natalie Joseph-Williams, University of Cardiff

  • Richard Thomson, University of Newcastle

  • Sophie Randall, Patient Information Forum.

Production

The project was delivered through the collaborative work of the following people:

  • Jonathan Berry, personalisation and control specialist, NHS England and NHS Improvement

  • Chris Carmona, senior technical analyst, NICE

  • Deborah Collis, associate director of system engagement, NICE

  • Amy Finnegan, information specialist, NICE

  • Andy Hutchinson, medicines education technical adviser, NICE

  • Johanna Hulme, associate director of medicines evidence and advice, NICE

  • Setal Bachelard, medical editor, NICE

  • Laura Norburn, senior operations manager, NICE

  • Trudie Pandolfo, business manager, NICE

  • Victoria Thomas, head of public involvement, NICE.

COVID -19 process

The process to develop this framework largely followed the process developed for NICE's COVID-19 rapid guidance development.

Literature review

The literature review is detailed in Appendix 2.

Peer and patient review

Drafts of the framework were reviewed by the oversight and delivery groups, and a targeted consultation took place with members of the NICE shared decision making collaborative and other key experts in the field.